Silver Book Fact

A 2002 study found that image-guided percutaneous needle biopsies are between 3 and 7 times more cost-effective than open surgical biopsies, require a shorter procedure time, result in fewer infections, and allow earlier treatment if cancer is found.

Jelinek, James S., Mark D. Murphey, James A. Welker, Robert M. Henshaw, Mark J. Kransdorf, Barry M. Shmookler, and Martin M. Malawer. Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 tumors. Radiology. 2002; 223: 731-7. http://radiology.rsnajnls.org/cgi/content/abstract/223/3/731

Reference

Title
Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 tumors
Publication
Radiology
Publication Date
2002
Authors
Jelinek, James S., Mark D. Murphey, James A. Welker, Robert M. Henshaw, Mark J. Kransdorf, Barry M. Shmookler, and Martin M. Malawer
Pages
731-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Drugs like bevacizumab- designed to impede the growth of blood vessels and tumors- can cost more than $100,000 per patient.   
  • As of July 2014, 18 anticancer drugs received FDA approval after being designated breakthrough therapies.  
  • Use of the Pap smear test is credited with cutting the age-adjusted cervical cancer incidence in half between 1975 and 2001, reducing it from 14.8 to 7.9 cases per 100,000…  
  • Improvement in 5-Year Survival Rates for All Cancers Since 1975
     
  • Decline in Cancer Death Rates in Men